Drug Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Drug Development stocks.

Drug Development Stocks Recent News

Date Stock Title
Nov 17 LDOS Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Nov 16 LDOS What Moved Markets This Week
Nov 15 SWTX Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report
Nov 14 LDOS S&P 500 Gains and Losses Today: Government Contractors Lose Ground, Tapestry Rises
Nov 14 MNMD Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions
Nov 14 LDOS Zacks.com featured highlights include Sterling, Leidos, Tenet Healthcare and Amazon
Nov 13 LDOS Pick These 4 Stocks With Solid Interest Coverage Ratio
Nov 13 LDOS Leidos announces $1.75 million gift to Drake State Community & Technical College
Nov 13 MNMD MindMed to Participate in Upcoming Investor Conferences
Nov 13 LDOS Q3 Earnings Outperformers: KBR (NYSE:KBR) And The Rest Of The Defense Contractors Stocks
Nov 13 SWTX SpringWorks Therapeutics Inc (SWTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Nov 13 BLTE Belite Bio, Inc 2024 Q3 - Results - Earnings Call Presentation
Nov 13 BLTE Belite Bio, Inc. (BLTE) Q3 2024 Earnings Call Transcript
Nov 12 BLTE Belite Bio GAAP EPS of -$0.28 beats by $0.01
Nov 12 SWTX SpringWorks Therapeutics, Inc. (SWTX) Q3 2024 Earnings Call Transcript
Nov 12 LDOS Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Nov 12 SWTX SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
Nov 12 RIGL Rigel to Present at the Jefferies London Healthcare Conference
Nov 12 LDOS Is Leidos Holdings (LDOS) Best Performing Cybersecurity Stock in 2024?
Nov 12 SWTX SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study
Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Browse All Tags